Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.
Open | $4.600 |
Close | $5.000 |
Volume / Avg. | 1.755M / 37.450K |
Day Range | 4.510 - 7.420 |
52 Wk Range | 1.010 - 7.120 |
Market Cap | $86.560M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.22% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aileron Therapeutics (NASDAQ: ALRN) through any online brokerage.
Other companies in Aileron Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Gritstone Bio (NASDAQ:GRTS), Cue Biopharma (NASDAQ:CUE) and Precision BioSciences (NASDAQ:DTIL).
The latest price target for Aileron Therapeutics (NASDAQ: ALRN) was reported by Ladenburg Thalmann on Thursday, April 18, 2024. The analyst firm set a price target for 19.00 expecting ALRN to rise to within 12 months (a possible 272.55% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $5.1 last updated April 18, 2024 at 7:06 PM EDT.
There are no upcoming dividends for Aileron Therapeutics.
Aileron Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Aileron Therapeutics.
Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.